Forte Biosciences FB102 shows vitiligo improvement in phase 1b trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. NOW
3. DHR
4. USO
5. NVDA
6. SPY
7. AMD
8. SMCI
9. TSLA
10. GM

Go back to Forte Biosciences FB102 shows vitiligo improvement in phase 1b trial
(NASDAQ: FBRX) Delayed: 56.63 --0 (-0%)
Previous Close $56.63    52 Week High $ 
Open $56.63    52 Week Low $ 
Day High $56.63    P/E N/A 
Day Low $56.63    EPS $ 
Volume 238